Does big data have a big problem? Dr. John W. Sweetenham cautions, "There is a real danger that we legitimize flawed data sets by labelling them as 'real-world data' when they neither reflect the real world...
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as...
ASCO’s Clinical Cancer Advances report, our 14th edition, examines the most transformative research of the past year and offers our vision for future research priorities.
Predictive analytics, complex treatment pathways, tele-oncology, and more: Dr. Robert M. Daly identifies five trends that are poised to disrupt oncology practice in the coming year.
